Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.
Explore key takeaways from ASCO 2025, from ctDNA and AI to novel biologics and inclusive trials. Learn how to stay ahead in oncology research.
A comprehensive guide exploring the challenges and best practices in cancer immunotherapy clinical trials.
See how next-gen CROs leverage AI, digital biomarkers, & trial designs to accelerate oncology drug development & regulatory approval.
Select the right Oncology CRO in 2025 using insights on innovative solutions & patient-focused trials to advance clinical development.
Discover heartwarming advances in clinical research for 2025, from AI-driven breakthroughs to advancements in personalized medicine.
Download our World Cancer Day infographic to discover the biggest cancer research breakthroughs of the past five years and future innovations in oncology.
Explore the latest advancements in cancer research on World Cancer Day 2025, from AI-powered breakthroughs to innovative immunotherapies.
